Stockreport

Plus Therapeutics, Inc. Announces Closing of $15 Million Underwritten Public Offering

PLUS THERAPEUTICS, Inc.  (PSTV) 
PDF AUSTIN, Texas, Sept. 26, 2019 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”) today announced the closing of its previously announced underw [Read more]